Panic disorder is perhaps the most dramatic and bewildering form of anxiety. It is characterized by sudden attacks of intense fear that reach their peak intensity within minutes.… Read more.
6 factors with evidence, ordered from highest to lowest effectiveness. Information, not medical advice.
⏱ 4 min read
Panic disorder is perhaps the most dramatic and disconcerting form of anxiety. It is characterized by sudden attacks of intense fear that reach their peak intensity within minutes. These attacks can include palpitations, chest pain or tightness, a feeling of suffocation, dizziness, nausea, tingling in the extremities, hot flashes or chills, and above all the terrifying sensation that you are going to die, go crazy, or lose control. They often occur without an obvious trigger, and that unpredictability is precisely what makes it a disorder: the person begins to develop a fear of the fear itself, avoids places where they already had an attack, and their life narrows around "safe zones."
The fear circuit fires before the conscious cortex understands what is going on. The amygdala detects an interoceptive change (a stronger heartbeat, a feeling of dizziness, slightly faster breathing) and interprets it as a mortal threat. Adrenaline and noradrenaline are released massively: the heart races, muscles tense, breathing becomes rapid and shallow. That hyperventilation lowers blood CO₂ (hypocapnia) and produces dizziness, tingling, and a feeling of unreality. The person interprets these physical symptoms as "something serious" (a heart attack, a stroke, madness), and the catastrophic interpretation intensifies the response. The attack burns out in 10-20 minutes because the adrenaline is metabolized, but the aversive learning remains: the brain registers that place/situation/sensation as dangerous, and avoids it next time.
In panic disorder, hypersensitivity to lactate, CO₂, and cholecystokinin has been documented (molecules that do not provoke panic in people without the disorder but trigger attacks in patients), which suggests a low threshold of the alarm system. The ventromedial prefrontal cortex shows hypoactivity, the amygdala hyperactivity, and there is evidence of reduced vagal tone (low HRV). This last finding is the biological basis for breathing interventions: if vagal tone is low, raising it with slow resonance breathing should have a measurable anxiolytic effect, and it does in trials.
High-dose inositol (12-18 g/day) has the most striking trial in panic: a crossover vs. fluvoxamine 150 mg (PMID 11386498) showed a similar reduction in attack frequency and severity at 4 weeks, with fewer adverse effects. It is a small sample (n=20) and has not been replicated at large scale, but for a molecule with no relevant toxicity and a safe profile it is an option to consider before or alongside an SSRI.
Cardiac coherence (breathing at 5.5 breaths/min) for 8 weeks as a component of HRV biofeedback reduces attack frequency and anticipatory anxiety. It is the breathing component of CBT for panic, and there is now enough evidence to use it as an initial intervention in mild-to-moderate cases. Five minutes, three times a day, with or without a device. No side effects, free, and with a solid physiological basis.
Silexan has preliminary data in panic (open-label studies, no robust double-blind RCTs), but its anxiolytic profile without daytime sedation fits well with panic profiles that have background anticipatory anxiety.
5-HTP has old trials with 5-HTP + carbidopa that showed a reduction in attacks, but the evidence is old and of low quality. Like any serotonergic agent, do NOT combine with SSRIs/MAOIs/triptans.
Glycine before bed may reduce anxious awakenings with palpitations (nocturnal panic), although direct clinical evidence is limited. NMDA modulation and a drop in core body temperature are coherent mechanisms.
In moderate-to-severe panic, SSRIs are first line (paroxetine, sertraline, escitalopram), with a response at 4-8 weeks. Benzodiazepines relieve symptoms quickly but generate tolerance and dependence; their use is justified for the acute attack (sublingual alprazolam) and in the first weeks until the SSRI takes effect, with a planned withdrawal. The combination of SSRI + CBT with interoceptive exposure has the best long-term response rate (60-80%) and the lowest relapse rate.
CBT for panic is not talking about the attack. It is deliberately exposing yourself to the feared physical sensations so that the brain learns they are not dangerous. Hyperventilating for 90 seconds to reproduce the dizziness and see that it passes. Running in place to speed up the heart and see that there is no heart attack. Spinning in a chair to provoke controlled dizziness. This interoceptive exposure breaks the aversive conditioning and gives control back. Without this work, no medication prevents relapse once it is withdrawn.
After a first panic attack, it is advisable to rule out a cardiac or thyroid cause (ECG, TSH, blood count). If the attacks recur, do not wait: panic disorder responds very well to structured treatment, and each week of avoidance consolidates the aversive learning that will later have to be undone.
⏱ 4 min read
Panic disorder is perhaps the most dramatic and disconcerting form of anxiety. It is characterized by sudden attacks of intense fear that reach their peak intensity within minutes. These attacks can include palpitations, chest pain or tightness, a feeling of suffocation, dizziness, nausea, tingling in the extremities, hot flashes or chills, and above all the terrifying sensation that you are going to die, go crazy, or lose control. They often occur without an obvious trigger, and that unpredictability is precisely what makes it a disorder: the person begins to develop a fear of the fear itself, avoids places where they already had an attack, and their life narrows around "safe zones."
The fear circuit fires before the conscious cortex understands what is going on. The amygdala detects an interoceptive change (a stronger heartbeat, a feeling of dizziness, slightly faster breathing) and interprets it as a mortal threat. Adrenaline and noradrenaline are released massively: the heart races, muscles tense, breathing becomes rapid and shallow. That hyperventilation lowers blood CO₂ (hypocapnia) and produces dizziness, tingling, and a feeling of unreality. The person interprets these physical symptoms as "something serious" (a heart attack, a stroke, madness), and the catastrophic interpretation intensifies the response. The attack burns out in 10-20 minutes because the adrenaline is metabolized, but the aversive learning remains: the brain registers that place/situation/sensation as dangerous, and avoids it next time.
In panic disorder, hypersensitivity to lactate, CO₂, and cholecystokinin has been documented (molecules that do not provoke panic in people without the disorder but trigger attacks in patients), which suggests a low threshold of the alarm system. The ventromedial prefrontal cortex shows hypoactivity, the amygdala hyperactivity, and there is evidence of reduced vagal tone (low HRV). This last finding is the biological basis for breathing interventions: if vagal tone is low, raising it with slow resonance breathing should have a measurable anxiolytic effect, and it does in trials.
High-dose inositol (12-18 g/day) has the most striking trial in panic: a crossover vs. fluvoxamine 150 mg (PMID 11386498) showed a similar reduction in attack frequency and severity at 4 weeks, with fewer adverse effects. It is a small sample (n=20) and has not been replicated at large scale, but for a molecule with no relevant toxicity and a safe profile it is an option to consider before or alongside an SSRI.
Cardiac coherence (breathing at 5.5 breaths/min) for 8 weeks as a component of HRV biofeedback reduces attack frequency and anticipatory anxiety. It is the breathing component of CBT for panic, and there is now enough evidence to use it as an initial intervention in mild-to-moderate cases. Five minutes, three times a day, with or without a device. No side effects, free, and with a solid physiological basis.
Silexan has preliminary data in panic (open-label studies, no robust double-blind RCTs), but its anxiolytic profile without daytime sedation fits well with panic profiles that have background anticipatory anxiety.
5-HTP has old trials with 5-HTP + carbidopa that showed a reduction in attacks, but the evidence is old and of low quality. Like any serotonergic agent, do NOT combine with SSRIs/MAOIs/triptans.
Glycine before bed may reduce anxious awakenings with palpitations (nocturnal panic), although direct clinical evidence is limited. NMDA modulation and a drop in core body temperature are coherent mechanisms.
In moderate-to-severe panic, SSRIs are first line (paroxetine, sertraline, escitalopram), with a response at 4-8 weeks. Benzodiazepines relieve symptoms quickly but generate tolerance and dependence; their use is justified for the acute attack (sublingual alprazolam) and in the first weeks until the SSRI takes effect, with a planned withdrawal. The combination of SSRI + CBT with interoceptive exposure has the best long-term response rate (60-80%) and the lowest relapse rate.
CBT for panic is not talking about the attack. It is deliberately exposing yourself to the feared physical sensations so that the brain learns they are not dangerous. Hyperventilating for 90 seconds to reproduce the dizziness and see that it passes. Running in place to speed up the heart and see that there is no heart attack. Spinning in a chair to provoke controlled dizziness. This interoceptive exposure breaks the aversive conditioning and gives control back. Without this work, no medication prevents relapse once it is withdrawn.
After a first panic attack, it is advisable to rule out a cardiac or thyroid cause (ECG, TSH, blood count). If the attacks recur, do not wait: panic disorder responds very well to structured treatment, and each week of avoidance consolidates the aversive learning that will later have to be undone.